Literature DB >> 8446978

Cerebral autoregulation during moderate hypothermia in rats.

M J Verhaegen1, M M Todd, B J Hindman, D S Warner.   

Abstract

BACKGROUND AND
PURPOSE: Little is known about the effects of hypothermia on cerebral autoregulation. The present study was designed to examine cerebral blood flow responses to controlled hemorrhagic hypotension in normothermic and hypothermic rats.
METHODS: Cortical blood flow was measured with a laser-Doppler flowmeter in halothane-anesthetized rats assigned to one of three groups: normothermic group 1 (n = 8) with a pericranial temperature of approximately 36.5 degrees C or hypothermic group 2 (n = 8) or group 3 (n = 8) with a pericranial temperature of approximately 30.5 degrees C. In group 2, a PaCO2 of approximately 40 mm Hg was maintained without correction for body temperature. To evaluate the role of PaCO2, in group 3 animals PaCO2 was kept at approximately 40 mm Hg as corrected for body temperature. In all animals, the mean arterial blood pressure was reduced by hemorrhage in increments of 10 mm Hg every 2 minutes.
RESULTS: In group 1 animals, a typical autoregulatory curve was observed with cerebral blood flow first falling at or below 75% of baseline at a mean arterial pressure of 57 +/- 15 mm Hg (mean +/- SD). Absolute normotensive cerebral blood flow in group 2 fell to < or = 75% of baseline at a mean arterial pressure of 73 +/- 21 mm Hg. In group 3, no evidence of autoregulation was seen. Cerebral blood flow reached values < or = 75% of baseline at a mean arterial pressure of 82 +/- 14 mm Hg, whereas calculated cerebrovascular resistance failed to show any compensatory vasodilation as the mean arterial pressure decreased.
CONCLUSIONS: Different PaCO2 management schemes used during hypothermia may have profound effects on cerebral blood flow and on autoregulation. If PaCO2 is maintained at 40 mm Hg after correction for temperature, autoregulation is abolished. If uncorrected PaCO2 is maintained at approximately 40 mm Hg, some degree of autoregulation is preserved, albeit with a right-shifted "knee."

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8446978     DOI: 10.1161/01.str.24.3.407

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  6 in total

1.  Elevated vertebrobasilar artery resistance in neonatal spontaneously hypertensive rats.

Authors:  Matthew J Cates; Peter W Steed; Ana P L Abdala; Philip D Langton; Julian F R Paton
Journal:  J Appl Physiol (1985)       Date:  2011-04-14

2.  What is the optimal anesthetic protocol for measurements of cerebral autoregulation in spontaneously breathing mice?

Authors:  Zhenghui Wang; Beat Schuler; Olga Vogel; Margarete Arras; Johannes Vogel
Journal:  Exp Brain Res       Date:  2010-10-24       Impact factor: 1.972

3.  Severe hypoxia and hypothermia following barbiturate poisoning.

Authors:  P Hantson; D Ziade; M Evenepoel; P Mahieu
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

4.  Low-dose but not high-dose prostaglandin E(1) improves the histological outcome of severe forebrain ischemia in rats.

Authors:  Yoshihide Miura; Kaoru Kanazawa; Noriko Yokoo; Kazue Iizawa; Masayuki Okada; Shinya Oda; Masaki Nakane
Journal:  J Anesth       Date:  2010-02-18       Impact factor: 2.078

Review 5.  The Critical Role of Spreading Depolarizations in Early Brain Injury: Consensus and Contention.

Authors:  R David Andrew; Jed A Hartings; Cenk Ayata; K C Brennan; Ken D Dawson-Scully; Eszter Farkas; Oscar Herreras; Sergei A Kirov; Michael Müller; Nikita Ollen-Bittle; Clemens Reiffurth; Omer Revah; R Meldrum Robertson; C William Shuttleworth; Ghanim Ullah; Jens P Dreier
Journal:  Neurocrit Care       Date:  2022-03-07       Impact factor: 3.532

6.  Cerebrovascular reactivity is not associated with therapeutic intensity in adult traumatic brain injury: a CENTER-TBI analysis.

Authors:  Frederick A Zeiler; Ari Ercole; Erta Beqiri; Manuel Cabeleira; Marcel Aries; Tommaso Zoerle; Marco Carbonara; Nino Stocchetti; Peter Smielewski; Marek Czosnyka; David K Menon
Journal:  Acta Neurochir (Wien)       Date:  2019-06-25       Impact factor: 2.216

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.